Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia
Roberto Ciarcia(Federico II University Hospital), Salvatore Florio(University of Naples Federico II), Maria Valeria Puzio(University of Naples Federico II), Francesco Pagnini(University of Parma), Cristiana Bellan(University of Siena), Giuseppe Caparrotti(Federico II University Hospital), Tiziana Garofano(University of Siena), Carmen Pacilio(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Serena Montagnaro(University of Naples Federico II), Maria Sole Polito(University of Siena), Sara Damiano(Federico II University Hospital), Antonio Giordano(University of Siena)
Cited by 21
Related Papers
Curcumin and Cancer
|Nutrients|2019|977
Role of p53 in the Regulation of Cellular Senescence
|Biomolecules|2020|605
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413